Marrone Bio Innovations (NASDAQ: MBII)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Marrone Bio Innovations (NASDAQ: MBII) through any online brokerage.
There are no as such competitors for Marrone Bio Innovations.
The latest price target for Marrone Bio Innovations (NASDAQ: MBII) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MBII to rise to within 12 months (a possible 401.19% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Marrone Bio Innovations (NASDAQ: MBII) is $0.7981 last updated July 12, 2022, 8:00 PM UTC.
The next Marrone Bio Innovations (MBII) dividend date is projected to be Thursday, September 1, 2022.
Marrone Bio Innovations’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Marrone Bio Innovations.
Marrone Bio Innovations is in the Basic Materials sector and Agricultural Inputs industry. They are listed on the NASDAQ.